← Back to Search

Other

Ketogenic Diet for Pediatric Brain Cancer

N/A
Waitlist Available
Led By Daniel Bowers, MD
Research Sponsored by Daniel Bowers
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients must be < 21 years of age inclusive at the time of enrollment on this protocol
Patients must have fully recovered from the acute toxic effects of all prior chemotherapy, immunotherapy, biologic therapy, or radiotherapy prior to entering this study
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 28 days
Awards & highlights

Study Summary

This trial is testing whether a strict ketogenic diet can be implemented in children with brain tumors that have returned or progressed after treatment. If successful, this diet could be used to help these children manage their brain tumors.

Who is the study for?
This trial is for children under 21 with recurrent or progressive brain tumors that haven't responded to standard treatments. They must have recovered from previous therapies, not be on other cancer treatments, and able to follow a strict diet either by mouth or tube. Pregnant individuals or those with certain health conditions like diabetes treated with medication are excluded.Check my eligibility
What is being tested?
The study tests the feasibility of a strict classic ketogenic diet in young patients with tough-to-treat brain tumors. Participants will start the diet in the hospital for 5 days and continue at home for a year, keeping daily logs and attending regular check-ups.See study design
What are the potential side effects?
Potential side effects may include digestive issues due to dietary changes, low blood sugar levels, possible kidney stones if there's a history of them, and nutrient deficiencies without proper management.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 21 years old or younger.
Select...
I have recovered from side effects of my previous cancer treatments.
Select...
My brain tumor is growing or returning despite treatment.
Select...
My tumor can be measured using specific imaging techniques.
Select...
I can do most of my daily activities without help.
Select...
I can eat by mouth or am willing to use a feeding tube if needed.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~28 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 28 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility (safety and tolerability) of the ketogenic diet

Trial Design

1Treatment groups
Experimental Treatment
Group I: Strict Classic Ketogenic Diet ArmExperimental Treatment1 Intervention
The classic ketogenic diet is individually calculated for each patient based on age, weight, and nutritional needs. The diet is typically administered from a 2:1 to 4:1 ratio; this means 2 to 4 parts of fat to 1 part of both protein (calculated based on RDA and whatever remaining portion of carbohydrates. The basis of calculations is first on the amount of required protein needed to meet RDA to insure adequate growth. Fine tuning of ketogenic diet therapy is based on serum beta-hydroxybutyrate levels (target levels of 3.5-6.5 mmol/L), tolerance of the diet, and response to treatment.

Find a Location

Who is running the clinical trial?

Daniel BowersLead Sponsor
University of Texas Southwestern Medical CenterLead Sponsor
1,047 Previous Clinical Trials
1,053,775 Total Patients Enrolled
Daniel Bowers, MDPrincipal InvestigatorUniversity of Texas Southwestern Medical Center

Media Library

Strict Classic Ketogenic Diet (Other) Clinical Trial Eligibility Overview. Trial Name: NCT03955068 — N/A
Pediatric Brain Tumor Research Study Groups: Strict Classic Ketogenic Diet Arm
Pediatric Brain Tumor Clinical Trial 2023: Strict Classic Ketogenic Diet Highlights & Side Effects. Trial Name: NCT03955068 — N/A
Strict Classic Ketogenic Diet (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03955068 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there opportunities to join this research project still available?

"Clinicaltrials.gov indicates that this medical trial, which originally launched on October 1st 2022 and was last updated April 20th of the same year, is not currently seeking applicants. Nevertheless, there are still 1413 additional clinical trials searching for participants at present."

Answered by AI
~16 spots leftby Jan 2026